TAFASITAMAB vs TALIMOGENE LAHERPAREPVEC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TAFASITAMAB vs TALIMOGENE LAHERPAREPVEC: Safety Overview
| Metric | TAFASITAMAB | TALIMOGENE LAHERPAREPVEC |
|---|---|---|
| Total FAERS Reports | 1,392 | 1,475 |
| Deaths Reported | 475 | 164 |
| Death Rate | 34.1% | 11.1% |
| Hospitalizations | 433 | 286 |
| Average Patient Age | 70.0 yrs | 66.7 yrs |
| % Female Patients | 50.1% | 48.3% |
| Manufacturer | Incyte Corporation | Amgen Inc |
| Route | INTRAVENOUS | INTRALESIONAL |